153 related articles for article (PubMed ID: 31446546)
21. What influences early hypothyroidism after radioiodine treatment for Graves' hyperthyroidism?
Vijayakumar V; Ali S; Nishino T; Nusynowitz M
Clin Nucl Med; 2006 Nov; 31(11):688-9. PubMed ID: 17053385
[TBL] [Abstract][Full Text] [Related]
22. Radioactive iodine therapy in Graves' hyperthyroidism: a prospective study from a tertiary referral centre in north India.
Sankar R; Sekhri T; Sripathy G; Walia RP; Jain SK
J Assoc Physicians India; 2005 Jul; 53():603-6. PubMed ID: 16190128
[TBL] [Abstract][Full Text] [Related]
23. Radioactive iodine therapy in Graves' hyperthyroidism.
Sankar R; Sripathy G
Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
[TBL] [Abstract][Full Text] [Related]
24. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
25. Radioiodine treatment of recurrent hyperthyroidism in patients previously treated for Graves' disease by subtotal thyroidectomy.
Vestergaard H; Laurberg P
J Intern Med; 1992 Jan; 231(1):13-7. PubMed ID: 1732393
[TBL] [Abstract][Full Text] [Related]
26. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease.
Uy HL; Reasner CA; Samuels MH
Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422
[TBL] [Abstract][Full Text] [Related]
27. [131I-therapy of Basedow's disease and nonimmunogenic hyperthyroidism].
Hoeschel M; Heinze HG
Nuklearmedizin; 1984 Jun; 23(3):143-9. PubMed ID: 6548309
[TBL] [Abstract][Full Text] [Related]
28. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
[TBL] [Abstract][Full Text] [Related]
29. The effect of short-term treatment with lithium carbonate on the outcome of radioiodine therapy in patients with long-lasting Graves' hyperthyroidism.
Sekulić V; Rajić M; Vlajković M; Ilić S; Stević M; Kojić M
Ann Nucl Med; 2017 Dec; 31(10):744-751. PubMed ID: 28895066
[TBL] [Abstract][Full Text] [Related]
30. Striving for euthyroidism in radioiodine therapy of Graves' disease: a 12-year prospective, randomized, open-label blinded end point study.
Chen DY; Schneider PF; Zhang XS; He ZM; Jing J; Chen TH
Thyroid; 2011 Jun; 21(6):647-54. PubMed ID: 21563916
[TBL] [Abstract][Full Text] [Related]
31. Pattern of presentation of Graves' disease and response to radioiodine therapy in South African men.
Onimode YA; Dairo DM; Ellmann A
Pan Afr Med J; 2018; 29():48. PubMed ID: 29875930
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
Chen DY; Chen TH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
[TBL] [Abstract][Full Text] [Related]
33. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
34. Quantitative mRNA expression analysis of selected genes in patients with early-stage hypothyroidism induced by treatment with iodine-131.
Guo K; Gao R; Yu Y; Zhang W; Yang Y; Yang A
Mol Med Rep; 2015 Nov; 12(5):7673-80. PubMed ID: 26398137
[TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves' disease based on the measurement of thyroid volume by ultrasonography.
Tsuruta M; Nagayama Y; Yokoyama N; Izumi M; Nagataki S
Ann Nucl Med; 1993 Aug; 7(3):193-7. PubMed ID: 8217496
[TBL] [Abstract][Full Text] [Related]
36. [Results of radioiodine therapy of manifest hyperthyroidism and autonomous struma with euthyroidism].
Berding G; Schicha H
Nuklearmedizin; 1990 Aug; 29(4):158-65. PubMed ID: 2216811
[TBL] [Abstract][Full Text] [Related]
37. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome.
Catargi B; Leprat F; Guyot M; Valli N; Ducassou D; Tabarin A
Eur J Endocrinol; 1999 Aug; 141(2):117-21. PubMed ID: 10427153
[TBL] [Abstract][Full Text] [Related]
38. Hypothyroidism after iodine-131 or surgical therapy for Graves' disease hyperthyroidism.
Gómez JM; Gómez N; Amat M; Biondo S; Rafecas A; Jaurrieta E; Soler J
Ann Endocrinol (Paris); 2000 Sep; 61(3):184-91. PubMed ID: 10970941
[TBL] [Abstract][Full Text] [Related]
39. 131-I radioiodine therapy for hyperthyroidism in patients with Graves' disease, uninodular goitre and multinodular goitre.
Danaci M; Feek CM; Notghi A; Merrick MV; Padfield PL; Edwards CR
N Z Med J; 1988 Nov; 101(858):784-6. PubMed ID: 3194075
[TBL] [Abstract][Full Text] [Related]
40. Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment.
Kinser JA; Roesler H; Furrer T; Grütter D; Zimmermann H
J Nucl Med; 1989 Dec; 30(12):1960-5. PubMed ID: 2585096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]